CoreAge Rx vs ReadyRx
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and ReadyRx head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 67 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make ReadyRx a bad call — it's best for readers comparing online glp-1 care who will confirm the chosen monthly or quarterly offer and request the full cancellation agreement. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | ReadyRx |
|---|---|---|
| Brief Score | 94/100 (A) | 67/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | Confirm the selected plan Monthly table: $229 first month, then $249/month. Hero advertises from $179 with a separate plan selection. Confirm the complete term, supplied quantity and cancellation agreement. Full price detailsCurrent selected compounded semaglutide plan quote unknown; rendered monthly table shows $229 first month then $249/month, while hero starts at $179; earlier listing: From $179/mo (starting dose, compounded) |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | Confirm the selected plan Monthly table: $295 first month, then $315/month. Hero advertises from $255 with a separate plan selection. Confirm the complete term, supplied quantity and cancellation agreement. Full price detailsCurrent selected compounded tirzepatide plan quote unknown; rendered monthly table shows $295 first month then $315/month, while hero starts at $255; earlier listing: From $255/mo (starting dose, compounded) |
| Coverage | US only; restrictions by state, confirmed at intake | Confirm treatment eligibility for your physical location; a current medication-specific state list was not established |
| Brand-name access | Not confirmed | Named Ozempic and Zepbound cards link to separate advertised treatment paths; current eligibility, complete brand-plan quote and pharmacy require confirmation. |
| Oral / sublingual | Injection only | Unconfirmed |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
ReadyRx: Monthly table: semaglutide $229 first month then $249; tirzepatide $295 then $315. Lower hero starts should not be assumed to price the same selection.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.